Axway Software S.A. (0P5L)
London Stock Exchange · UK · prices in EUR · close of 26 Oct 2026
Key indicators
| Last close | EUR 38.20 |
|---|---|
| 52-week range | 26.90 – 41.70 |
| Return, 1 month / 3 months | −1.0% / +10.4% |
| Return, 1 year / 3 years | +9.8% / +92.3% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 32.6% |
| Worst drawdown (1 year) | -35.5% |
| Average daily value traded | 0.00M EUR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Axway Software is a software company based in France that helps organisations connect their systems, applications and business partners. It provides API management, business-to-business integration and managed file transfer products, along with related services and support. Its customers are mainly large enterprises and public organisations that need to exchange data securely and manage integrations across their operations. The company also offers cloud-based versions of its integration tools.
The shares are listed on the London Stock Exchange in UK under the code 0P5L, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Axway Software S.A. (0P5L) trades on the London Stock Exchange in UK. It last closed at EUR 38.20 on 26 October 2026.
Its price-based Market X-Ray is 52 out of 100 (a fair price profile), ranking 1,933 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 9.8% and over the last three months it rose 10.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 5.2% | ||
| From 52-week high | -8.4% | ||
| Momentum | 70 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 10.4% | ||
| 6-month return | 10.4% | ||
| 12-month return, skipping the last month | 10.9% | ||
| Stability (higher is calmer) | 47 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 32.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.5% | ||
| Liquidity | 6 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M EUR | ||
| Zero-volume days | 41.7% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +1.6% |
|---|---|
| 1 month | −1.0% |
| 3 months | +10.4% |
| 6 months | +10.4% |
| 1 year | +9.8% |
| 3 years | +92.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 37.72 / 36.30 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.71 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 Jun 2023 | USD 0.4000 |
| 6 Jun 2022 | USD 0.4000 |
| 16 Jun 2021 | USD 0.4000 |
| 2 Jul 2019 | USD 0.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.